Peptides are not one treatment category.
“Peptides” describes a broad group of compounds with different mechanisms, evidence bases, regulatory positions and safety considerations. Online discussion often compresses all of this into promises about recovery, body composition, sleep or longevity. That is not a sound basis for medical treatment.
The consultation is designed to define your actual goal, assess more established medical options and discuss any peptide only in the context of available evidence and current South African requirements.
What will be discussed
- Your symptoms, medical history, medication and current supplements
- The outcome you are trying to achieve and how it could be measured
- Quality of evidence for the proposed compound
- Known and uncertain adverse effects
- Regulatory status, sourcing and quality concerns
- Evidence-based alternatives and reasons not to treat
- Monitoring and clear stop criteria if treatment is appropriate
A useful consultation can end with “no.”
If the expected benefit is unclear, the product is unsuitable, the risk is disproportionate or a more established treatment is available, Dr Luhard will say so. That is part of the value of medical review.
Do not buy first and ask later.
Avoid starting an unverified online product and then seeking medical supervision after the fact. Unknown purity, dosing accuracy, storage and sterility can materially change risk.